2m 2m 2m 2m 2m 2m 2m
KALA BIO (KALA)
NASDAQ
$3.13+$0.005 (+0.16%)
Price as of Jun 23, 2026 7:33 PM EDT- $65.8MMarket Cap
- -98.44%1-Year Change
- BiotechnologyIndustry
KALA BIO (KALA)
$3.13+$0.005 (+0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | 0 -100.00% | 3.9M -65.37% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 3.9M -65.37% | |
Sales and Marketing Expense | 0 N/A | 0 -100.00% | 20.6M -68.38% | 65.0M -38.10% | |
Research and Development Expense | -18.8M -15.00% | -22.1M +18.87% | -18.6M -58.02% | -44.3M +16.10% | |
Depreciation and Amortization Expense | 317,000 +22.39% | 259,000 -14.52% | 303,000 -43.58% | 537,000 -44.92% | |
Total Operating Expenses | 39.2M -4.45% | 41.0M +3.33% | 39.7M -53.66% | 85.6M -39.50% | |
Operating Profit | -39.2M -4.45% | -41.0M +3.33% | -39.7M -51.46% | -81.7M -37.27% | |
Interest Income | 1.1M -44.55% | 2.1M -24.16% | 2.7M +308.28% | 664,000 +538.46% | |
Interest Expense | -2.8M -37.98% | -4.5M -22.29% | -5.8M -19.98% | -7.3M -13.29% | |
Interest Income and Expense and Net | -1.7M -32.49% | -2.5M -20.66% | -3.1M -53.00% | -6.6M -20.23% | |
Total Nonoperating Income and Expense | 12.2M +392.76% | 2.5M +197.48% | -2.5M -106.88% | 36.9M +340.14% | |
Income before Taxes | -27.0M -29.94% | -38.5M -8.74% | -42.2M -5.85% | -44.8M -68.57% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -27.0M -29.94% | -38.5M -8.74% | -42.2M -5.85% | -44.8M -68.57% | |
Net Income from Continuing Operations Applicable to Common | -27.0M -29.94% | -38.5M -8.74% | -42.2M -5.85% | -44.8M -68.57% | |
Basic EPS and Net Income | -3.31 -67.39% | -10.15 -41.50% | -17.35 -41.15% | -29.48 +1,246.12% | |
Diluted EPS and Net Income | -3.31 -67.39% | -10.15 -41.50% | -17.35 -41.15% | -29.48 +1,246.12% | |
Basic Weighted Average Shares | 8.1M +114.65% | 3.8M +56.09% | 2.4M +59.94% | 1.5M -97.67% | |
Diluted Weighted Average Shares | 8.1M +114.65% | 3.8M +56.09% | 2.4M +59.94% | 1.5M -97.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.6M -85.23% | 51.2M +0.56% | 50.9M -27.80% | 70.5M -23.49% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.6M -85.23% | 51.2M +0.56% | 50.9M -27.80% | 70.5M -58.14% | |
Total Current Assets | 9.5M -82.03% | 52.8M -0.14% | 52.9M -38.48% | 85.9M -30.90% | |
Accumulated Depreciation | 869,000 -33.87% | 1.3M +18.38% | 1.1M -9.31% | 1.2M -57.22% | |
Property and Plant and Equipment and Net | 749,000 0.00% | 749,000 -0.53% | 753,000 +88.25% | 400,000 -85.30% | |
Total Long-Term Assets | 749,000 0.00% | 749,000 -0.53% | 753,000 +88.25% | 400,000 -85.30% | |
Total Assets | 9.5M -82.90% | 55.5M -0.83% | 55.9M -35.56% | 86.8M -37.73% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 10.3M 0.00% | 10.3M +106.72% | 5.0M 0.00% | 5.0M +1,011.11% | |
Total Current Liabilities | 2.5M -85.29% | 17.0M +103.16% | 8.3M -67.51% | 25.7M -31.36% | |
Total Long-Term Debt | 20.1M 0.00% | 20.1M -41.21% | 34.2M -9.88% | 37.9M -51.94% | |
Total Long-Term Liabilities | 26.2M 0.00% | 26.2M -34.67% | 40.1M -4.89% | 42.2M -50.52% | |
Total Liabilities | 2.5M -94.22% | 43.2M -10.93% | 48.4M -28.60% | 67.8M -44.67% | |
Retained Earnings | -694.9M +4.04% | -667.9M +6.12% | -629.4M +7.19% | -587.2M +8.26% | |
Total Stockholders Equity | 7.0M -43.27% | 12.3M +64.34% | 7.5M -60.45% | 19.0M +12.91% | |
Total Shares Outstanding | 27.8M +357.21% | 6.1M +120.75% | 2.8M +61.65% | 1.7M -97.39% | |
Cash Flow | |||||
Cash from Operating Activities | -32.0M +8.88% | -29.4M +5.21% | -27.9M -64.61% | -78.9M -27.10% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -15,000 -92.79% | -208,000 -51.52% | -429,000 -100.68% | 62.7M -11.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -11.6M -138.89% | 29.9M +251.23% | 8.5M +207.10% | -7.9M -118.66% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -2,099.33% +81.17% | |
Return on Assets | -83.05% +20.15% | -69.12% +16.92% | -59.12% +49.20% | -39.62% -49.84% | |
Return on Equity | -279.18% -28.10% | -388.29% +21.82% | -318.75% +27.22% | -250.56% +2.61% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% +52.97% | -65.37% -185.26% | |
Current Ratio | 3.81 +22.20% | 3.11 -50.85% | 6.33 +89.32% | 3.35 +0.68% | |
Cash Ratio | 3.03 +0.38% | 3.02 -50.50% | 6.10 +122.19% | 2.74 +11.47% | |
Debt-to-Equity Ratio | 4.35 +76.27% | 2.47 -52.74% | 5.22 +130.79% | 2.26 -52.10% | |
Debt-to-Assets Ratio | 3.21 +484.65% | 0.55 -21.68% | 0.70 +41.63% | 0.49 -13.12% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow